A carregar...
Predictive Factors for Second-Line Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Analysis
Currently, about 50% of patients with metastatic renal cell carcinoma (mRCC) receive a second-line therapy. Therefore, the choice at each subsequent treatment line remains an important issue. In this retrospective study, we sought to identify pretreatment clinical parameters that could predict the l...
Na minha lista:
| Publicado no: | J Kidney Cancer VHL |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Codon Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5364333/ https://ncbi.nlm.nih.gov/pubmed/28405544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15586/jkcvhl.2017.59 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|